إعلان
إعلان
INO
Inovio Pharmaceuticals, Inc.
1.56
USDبرعاية
-0.05
-2.80%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
1.56
0.00
+0.32%
تقارير أرباح INO
النسبة الإيجابية المفاجئة
INO تفوق 18 من 40 آخر التقديرات.
45%
التقرير التالي
بيانات التقرير القادم
١٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.36
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-58.62%
التغير الضمني من Q4 24 (Revenue/ EPS)
-100.00%
/-40.00%
Inovio Pharmaceuticals, Inc. earnings per share and revenue
On ١٠ نوفمبر ٢٠٢٥, INO reported earnings of -0.87 USD per share (EPS) for Q3 25, missing the estimate of -0.42 USD, resulting in a -103.56% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -6.98% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 المحللين forecast an EPS of -0.36 USD, with revenue projected to reach -- USD, implying an نقصان of -58.62% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Inovio Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Inovio Pharmaceuticals, Inc. reported EPS of -$0.87, missing estimates by -103.56%, and revenue of $0.00, 0% as expectations.
How did the market react to Inovio Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved down -6.98%, changed from $2.15 before the earnings release to $2.00 the day after.
When is Inovio Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for ١٦ مارس ٢٠٢٦.
What are the forecasts for Inovio Pharmaceuticals, Inc.'s next earnings report?
Based on 7
المحللين, Inovio Pharmaceuticals, Inc. is expected to report EPS of -$0.36 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان